Reportlinker Adds Medical Imaging Reagents and Analysis Equipment

Jan 04, 2010, 09:13 ET from Reportlinker

NEW YORK, Jan. 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Imaging Reagents and Analysis Equipment

http://www.reportlinker.com/p0170501/Medical-Imaging-Reagents-and-Analysis-Equipment.html

THIS REPORT

Examine the supporting products that have enhanced imaging at the chemical level (reagents and contrast media) and at the analysis level (software tools and image management)

Provide market data for 2008 and 2009, and forecast the compound annual growth rate (CAGR) for the period 2009-2014

Explain how existing medical imaging modalities such as magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and nuclear medicine are finding new applications through the development of specialized imaging reagents

Assess the major medical applications, market players, recent patents, and emerging technologies in reagents, analysis, and image management

Chapter- 1: INTRODUCTION -- Complimentary

STUDY OBJECTIVES 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 2

SCOPE OF THE STUDY 2

METHODOLOGY 2

INFORMATION SOURCES 2

ABOUT THE AUTHOR 2

RELATED BCC RESEARCH REPORTS 3

BCC ONLINE SERVICES 3

DISCLAIMER 3

Chapter-2: SUMMARY

SUMMARY 4

SUMMARY TABLE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), THROUGH 2014 ($ MILLIONS) 5

SUMMARY FIGURE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), 2007-2014 ($ MILLIONS) 6

Chapter-3: OVERVIEW

WHAT IS MEDICAL IMAGING 7

HISTORY OF MEDICAL IMAGING 7

TABLE 1 HISTORY OF MEDICAL IMAGING, 1895-1993 7

TYPES OF MEDICAL IMAGING 8

X-RAY IMAGING 8

Applications of X-ray in Medicine 8

TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY IMAGING 9

ULTRASOUND 9

Applications of Ultrasound 9

TABLE 3 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 10

MAGNETIC RESONANCE IMAGING 10

Applications of Magnetic Resonance Imaging 11

TABLE 4 ADVANTAGES AND DISADVANTAGES OF MAGNETIC RESONANCE IMAGING 11

COMPUTED TOMOGRAPHY 12

Applications of Computed Tomography 12

TABLE 5 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 13

POSITRON EMISSION TOMOGRAPHY 13

Applications of Positron Emission Tomography 14

TABLE 6 ADVANTAGES AND DISADVANTAGES OF POSITRON EMISSION TOMOGRAPHY 14

DIFFERENTIATION BETWEEN VARIOUS IMAGING TECHNIQUES 15

TABLE 7 DIFFERENCES BETWEEN CT AND PET 15

TABLE 8 DIFFERENCES BETWEEN CT AND MRI 15

CONTRAST AGENTS OR IMAGING REAGENTS 15

PROPERTIES OF AN IDEAL CONTRAST AGENT 16

CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES 16

Positive Contrast Agents 16

Barium 16

Iodine-based Contrast Agents 17

Negative Contrast Agents 17

CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING TECHNIQUE 17

Contrast Agents for X-Ray 18

Contrast Agents for Magnetic Resonance Imaging 18

Contrast Agents for Ultrasound 19

PET Radiopharmaceuticals 19

TABLE 9 COMPOUNDS USED IN PET SCAN 20

IMAGING EQUIPMENT 20

X-RAY IMAGING SYSTEM 20

FLUOROSCOPY EQUIPMENT 21

COMPUTED TOMOGRAPHY SCANNER 21

ULTRASOUND MACHINES 22

Bedside Doppler 23

Duplex Doppler 23

Color Doppler 23

Power Doppler 23

MAGNETIC RESONANCE IMAGING SYSTEM 24

Conventional MRI Units 24

Short-bore MRI Units 25

Open MRI Units 25

Mobile MRI Units 25

Dedicated Extremity/Head/Breast MRI units 25

POSITRON EMISSION TOMOGRAPHY EQUIPMENT 25

Chapter-4: REGULATORY ASPECTS

COMPUTED TOMOGRAPHY 26

ULTRASOUND 27

POSITRON EMISSION TOMOGRAPHY 27

NEED FOR CHANGE IN CURRENT GOOD MANUFACTURING PRACTICES REQUIREMENTS 28

APPROVALS IN THE FIELD OF MEDICAL IMAGING 28

TABLE 10 APPROVALS OF IMAGING AGENTS: 2006 THROUGH SEPTEMBER 2009 28

TABLE 11 APPROVALS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29

TABLE 12 RECALLS OF IMAGING REAGENTS: 2006 THROUGH SEPTEMBER 2009 29

TABLE 13 RECALLS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 29

Chapter-5: INDUSTRY STRUCTURE

MANUFACTURERS/ PRODUCTS FOR CONTRAST AGENTS/ IMAGING REAGENTS 30

TABLE 14 LEADING MANUFACTURERS OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS 30

TABLE 14 (CONTINUED) 31

TABLE 15 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS 31

TABLE 16 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS 31

TABLE 16 (CONTINUED) 32

TABLE 17 LEADING MANUFACTURERS OF RADIOPHARMACEUTICALS 32

TABLE 17 (CONTINUED) 33

TABLE 17 (CONTINUED) 34

MANUFACTURERS/ PRODUCTS FOR IMAGING SYSTEMS/ EQUIPMENT 34

TABLE 18 LEADING MANUFACTURERS OF RADIOGRAPHY (X-RAY, FLUOROSCOPY AND MAMMOGRAPHY) IMAGING SYSTEMS 34

TABLE 18 (CONTINUED) 35

TABLE 19 LEADING MANUFACTURERS OF COMPUTED TOMOGRAPHY SYSTEMS 36

TABLE 20 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS 36

TABLE 20 (CONTINUED) 37

TABLE 20 (CONTINUED) 38

TABLE 21 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING SYSTEMS 39

TABLE 22 LEADING MANUFACTURERS OF POSITRON EMISSION TOMOGRAPHY SYSTEMS 40

MARKET SHARES OF INDUSTRY LEADERS 40

CONTRAST AGENTS/ IMAGING REAGENTS 40

X-Ray and Computed Tomography Reagents 40

TABLE 23 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) 41

FIGURE 1 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) 41

Ultrasound Contrast Agents 42

TABLE 24 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 42

FIGURE 2 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 (%) 42

Magnetic Resonance Imaging Agents 43

TABLE 25 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) 43

FIGURE 3 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) 43

Radiopharmaceuticals 44

TABLE 26 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44

FIGURE 4 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) 44

IMAGING SYSTEMS/ EQUIPMENT 45

X-Ray Imaging Systems 45

TABLE 27 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45

FIGURE 5 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) 45

Computed Tomography Imaging Systems 46

TABLE 28 GLOBAL MARKET SHARES OF COMPUTED TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) 46

FIGURE 6 GLOBAL MARKET SHARES OF COMPUTED X-RAY IMAGING SYSTEMS, 2009 (%) 46

Ultrasound Imaging Systems 47

TABLE 29 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47

FIGURE 7 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) 47

Magnetic Resonance Imaging Systems 48

TABLE 30 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) 48

FIGURE 8 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) 48

Positron Emission Tomography Imaging Systems 49

TABLE 31 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY SYSTEMS, 2009 49

FIGURE 9 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) 49

Chapter-6: NEW DEVELOPMENTS

ULTRASOUND 50

TABLE 32 NEW DEVELOPMENTS IN THE FIELD OF ULTRASOUND IMAGING, 2007-2009 50

TABLE 32 (CONTINUED) 51

TABLE 32 (CONTINUED) 52

MAGNETIC RESONANCE IMAGING 52

TABLE 33 NEW DEVELOPMENTS IN THE FIELD OF MAGNETIC RESONANCE IMAGING 52

TABLE 33 (CONTINUED) 53

COMPUTED TOMOGRAPHY 53

TABLE 34 NEW DEVELOPMENTS IN THE FIELD OF COMPUTED TOMOGRAPHY IMAGING 53

X-RAY SYSTEMS 54

TABLE 35 NEW DEVELOPMENTS IN THE FIELD OF X-RAY IMAGING 54

POSITRON EMISSION TOMOGRAPHY 54

TABLE 36 NEW DEVELOPMENTS IN THE FIELD OF POSITRON EMISSION TOMOGRAPHY IMAGING 54

Chapter-7: MARKETS

IMAGING REAGENTS/ CONTRAST AGENTS 55

X-RAY AND CT CONTRAST AGENTS 55

Market Overview 55

Market Revenue 56

TABLE 37 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 56

FIGURE 10 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 57

Market Shares 57

TABLE 38 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 58

FIGURE 11 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 58

ULTRASOUND CONTRAST AGENTS 58

Market Overview 59

Market Revenue 60

TABLE 39 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 60

FIGURE 12 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 60

Market Share 61

TABLE 40 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 61

FIGURE 13 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 62

MRI CONTRAST AGENTS 62

Market Overview 62

Market Overview (Continued) 63

Market Revenue 64

TABLE 41 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) 64

FIGURE 14 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) 64

Market Share 65

TABLE 42 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 65

FIGURE 15 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) 65

RADIOPHARMACEUTICALS 66

Market Overview 66

Market Revenue 67

TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, THROUGH 2014 ($ MILLIONS) 67

FIGURE 16 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, 2007-2014 ($ MILLIONS) 67

Market Share 68

TABLE 44 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68

FIGURE 17 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) 68

IMAGING SYSTEMS/ EQUIPMENT 69

X-RAY IMAGING SYSTEMS 69

Market Overview 69

Market Revenue 70

TABLE 45 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 70

FIGURE 18 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 70

Market Share 71

TABLE 46 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71

FIGURE 19 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 71

COMPUTED TOMOGRAPHY IMAGING SYSTEMS 72

Market Overview 72

Market Revenue 73

TABLE 47 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 73

FIGURE 20 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 73

Market Share 74

TABLE 48 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 74

FIGURE 21 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 74

ULTRASOUND IMAGING SYSTEMS 75

Market Overview 75

Market Revenue 76

TABLE 49 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 76

FIGURE 22 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 76

Market Share 77

TABLE 50 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 77

FIGURE 23 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 77

MAGNETIC RESONANCE IMAGING SYSTEMS 78

Market Overview 78

Market Revenue 79

TABLE 51 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 79

FIGURE 24 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) 79

Market Share 80

TABLE 52 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 80

FIGURE 25 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 80

POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS 80

Market Overview 81

Market Revenue 82

TABLE 53 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION THROUGH 2014 ($ MILLIONS) 82

FIGURE 26 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) 82

Market Share 83

TABLE 54 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 83

FIGURE 27 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) 83

Chapter-8: MARKET BY APPLICATIONS

MARKET SHARE OF APPLICATIONS 84

TABLE 55 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85

FIGURE 28 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) 85

CARDIOVASCULAR DISEASE DIAGNOSIS 85

MARKET REVENUE 86

TABLE 56 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, THROUGH 2014 ($ MILLIONS) 86

FIGURE 29 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2007-2014 ($ MILLIONS) 87

MARKET SHARE 87

TABLE 57 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) 87

FIGURE 30 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) 88

ONCOLOGY DISEASE DIAGNOSIS 88

MARKET REVENUE 89

TABLE 58 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, THROUGH 2014 ($ MILLIONS) 89

FIGURE 31 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, 2007-2014 ($ MILLIONS) 90

MARKET SHARE 90

TABLE 59 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) 90

FIGURE 32 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) 91

CENTRAL NERVOUS SYSTEM DIAGNOSIS 91

MARKET REVENUE 92

TABLE 60 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, THROUGH 2014 ($ MILLIONS) 92

FIGURE 33 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2007-2014 ($ MILLIONS) 93

MARKET SHARE 93

TABLE 61 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) 93

FIGURE 34 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) 94

GASTROINTESTINAL (GI) SYSTEM DIAGNOSIS 94

MARKET REVENUE 95

TABLE 62 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, THROUGH 2014 ($ MILLIONS) 95

FIGURE 35 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2007-2014 ($ MILLIONS) 95

MARKET SHARE 96

TABLE 63 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) 96

FIGURE 36 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) 96

OTHERS 97

MARKET REVENUE 97

TABLE 64 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, THROUGH 2014 ($ MILLIONS) 97

FIGURE 37 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, 2007-2014 ($ MILLIONS) 97

MARKET SHARE 98

TABLE 65 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) 98

FIGURE 38 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) 98

Chapter-9: PATENT ANALYSIS

PATENT ANALYSIS 99

PATENTS BY YEAR 99

TABLE 66 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 100

FIGURE 39 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 (NUMBER) 100

FIGURE 40 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, 2005-2009 (%) 101

PATENTS BY TYPE 101

TABLE 67 PATENTS BY TYPE FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 102

FIGURE 41 PATENTS BY TYPE OF CONTRAST AGENT, 2005-2009 (NUMBER) 102

TABLE 68 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103

FIGURE 42 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) 103

PATENTS BY COMPANY 103

TABLE 69 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 104

FIGURE 43 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) 104

TABLE 70 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 105

FIGURE 44 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 106

PATENTS BY COUNTRY 106

TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 107

FIGURE 45 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 107

TABLE 72 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108

FIGURE 46 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) 108

TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 109

FIGURE 47 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 109

TABLE 74 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110

FIGURE 48 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) 110

PATENTS BY ASSIGNEE 110

TABLE 75 NUMBER OF PATENTS BY ASSIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009 111

FIGURE 49 NUMBER OF PATENTS BY ASSIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009 111

TABLE 76 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112

FIGURE 50 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 112

Chapter-10: CURRENT SITUATION OF IMAGING MARKET

CONTRAST AGENT MARKET SITUATION 113

IMAGING SYSTEMS MARKET SITUATION 113

IMAGING SYSTEMS MARKET ... (CONTINUED) 114

IMAGING SYSTEMS MARKET ... (CONTINUED) 115

FACTORS AFFECTING THE IMAGING MARKET 116

REGULATORY ACTIONS 116

AGING POPULATION 116

COMPETITION 116

TECHNOLOGICAL ADVANCEMENTS 117

SETBACKS IN INDUSTRY 117

Chapter-11: COMPANY PROFILES

ALOKA CO. LTD. 118

AMAG PHARMACEUTICALS INC. 118

ANALOGIC CORPORATION 119

BAYER HEALTHCARE PHARMACEUTICALS 119

COVIDIEN 120

ECHOSON SA (PL) 121

ESAOTE S.P.A 121

E-Z-EM INC 122

FONAR CORPORATION 122

GE HEALTHCARE MEDICAL DIAGNOSTICS 123

GUERBET LLC 124

HITACHI MEDICAL SYSTEMS AMERICA INC 124

HOLOGIC INC 125

IN VIVO CORPORATION 125

LANTHEUS MEDICAL IMAGING 126

BLDG. 200-2 126

MALLINCKRODT 126

MDS NORDION 127

MEDISON AMERICA INC 127

MILLENNIUM TECHNOLOGIES LTD. 128

ONI MEDICAL SYSTEMS INC. 128

PARADIGM MEDICAL INDUSTRIES 129

PARAMED MEDICAL SYSTEMS INC. 129

PHILIPS HEALTHCARE 129

POSITRON CORPORATION 130

SHIMADZU CORPORATION 131

SIEMENS AG 131

SONOSITE INC 132

TELEMED LTD. 133

TERASON ULTRASOUND 133

TIME MEDICAL INC 134

TOMTEC IMAGING SYSTEMS 134

TOSHIBA AMERICA INC 135

TRIAD ISOTOPES INC 135

ULTRASONIX MEDICAL CORP. 136

VOLCANO CORPORATION 137

ZONARE MEDICAL SYSTEMS INC. 137

APPENDIX: ABBREVIATIONS 138

To order this report:

Chemical Industry: Medical Imaging Reagents and Analysis Equipment

More Market Research Report


    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.Reportlinker.com